Author

J. Fujita

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. C. Ramalho· 1 shared A. Marques-Ramos· 1 shared A. Umemura· 1 shared B. Pereira· 1 shared H. Akiba· 1 shared H. Higashitsuji· 1 shared H. Kamada· 1 shared H. Ohno· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. C. Ramalho

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 3, 2023

Internal Translation of p53 Oncoproteins During Integrated Stress Response Confers Survival Advantage on Cancer Cells

M. J. Lopez-Iniesta, R. Lacerda, A. C. Ramalho…·M. M. Candeias

This study identifies the integrated stress response (ISR) as a trigger for p53 oncoprotein variants, showing their role in cancer cell survival and proposing a therapeutic strategy.

DOI 10.1101/2023.03.03.531004

humanproteomics

𝕏 PostBluesky

BiochemistrybioRxivDec 15, 2022

Development of a 1:1-binding biparatopic anti-TNFR2 antagonist by epitope selection

H. Akiba, J. Fujita, T. Ise…·K. Tsumoto

This study develops a biparatopic anti-TNFR2 antagonist that binds in a 1:1 ratio, preventing unwanted signal transduction and suppressing regulatory T cell proliferation.

DOI 10.1038/s42003-023-05326-8

experimental assayhost-pathogen & immune response

𝕏 PostBluesky

Cancer BiologybioRxivPreprintSep 20, 2022

Onecut1 partially contributes to liver progenitor cell transition and acquisition of metastatic potential in hepatocellular carcinoma.

Y. Liu, H. Higashitsuji, K. Itoh…·J. Fujita

DOI 10.1101/2022.09.20.508738

humanexperimental assay

𝕏 PostBluesky